Uccelli, A., Laroni, A., Ali, R., Battaglia, M. A., Blinkenberg, M., Brundin, L., Clanet, M., Fernandez, O., Marriott, J., Muraro, P., Nabavi, S. M., Oliveri, R. S., Radue, E., Ramo Tello, C., Schiavetti, I., Sellner, J., Sorensen, P. S., Sormani, M. P., Wuerfel, J. T., Freedman, M. S., & , (2021). safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet neurology, 20(11), 917–929. http://access.bl.uk/ark:/81055/vdc_100174355663.0x00001d